ArticleslgStudy

science

RTI-5152-12

RTI-5152-12 is a science topic covered in the lgStudy science library. This page brings together a partial reference excerpt, illustrations, worked examples, real-world applications and a short study plan, so you can understand RTI-5152-12 rather than just read about it. In short: RTI-5152-12, or WW-12 (in patent), is a synthetic small-molecule agonist of the atypical chemokine receptor ACKR3 (CXCR7) that was derived from the naturally occurring alkaloid conolidine. RTI-5152-12 has 15-fold improved potency towards ACKR3 relative to conolidine.

RTI-5152-12 — main illustration
RTI-5152-12 — illustration

Key takeaways

  • RTI-5152-12 belongs to science; place it in that map before memorising details.
  • Learn the definition first, then one example that makes the definition concrete.
  • Connect RTI-5152-12 to a quantity you can measure, compute or draw — that is where exam questions come from.
  • Reproduce the core statement of RTI-5152-12 from memory before moving on to harder problems.

Reference excerpt

RTI-5152-12, or WW-12 (in patent), is a synthetic small-molecule agonist of the atypical chemokine receptor ACKR3 (CXCR7) that was derived from the naturally occurring alkaloid conolidine. RTI-5152-12 has 15-fold improved potency towards ACKR3 relative to conolidine. ACKR3 is a novel opioid receptor which functions as a broad-spectrum trap or scavenger for endogenous opioid peptides, including enkephalins, dynorphins, and nociceptin. The receptor acts as a negative modulator of the opioid system by decreasing the availability of opioid peptides for their classical receptors like the μ-opioid receptor. Ligands of ACKR3, by competitively displacing endogenous opioid peptides from ACKR3, can potentiate the actions of these endogenous opioids and produce effects like analgesia and anxiolysis in animals. RTI-5152-12 is being developed as a potential pharmaceutical drug and, as of December 2021, is in the preclinical stage of development for treatment of pain. The chemical structure was not disclosed until a patent was published in June 2022.

See also LIH383

References

External links The Good Drug Guide - Conolidine / RTI-5152-12 - David Pearce

Illustrations

RTI-5152-12 illustration

Worked examples

Example 1 — a first encounter with RTI-5152-12

Start with the simplest possible case. Write down what RTI-5152-12 claims or describes in one sentence, then invent the smallest concrete situation in which that sentence is true. In science, the smallest case is usually a single object, a single equation or a single measurement. Check that every symbol or term in your sentence has a meaning in that case.

Example 2 — changing one variable

Take the situation from Example 1 and change exactly one quantity: double it, halve it, or set it to zero. Predict what should happen to RTI-5152-12 before you calculate. Comparing your prediction with the result is the fastest way to find out whether you understand the idea or only the words.

Example 3 — an exam-style question

Typical questions about RTI-5152-12 ask you to (a) state it precisely, (b) apply it to given data, and (c) explain a limitation. Practise writing all three answers in under five minutes; the third part is what separates a full-mark answer from an average one.

Applications of RTI-5152-12

In research
RTI-5152-12 appears in science research whenever the underlying quantities have to be modelled precisely. Papers usually cite it as a starting assumption and then explore where it breaks down.
In technology and industry
Engineering practice reuses RTI-5152-12 in design rules, simulations and safety margins. Knowing the idea lets you read a specification sheet and understand why the numbers look the way they do.
In the classroom
RTI-5152-12 is common in secondary-school and first-year university syllabi. It links to neighbouring topics Indoles, Ketones, Opioid modulators, so understanding it makes those chapters shorter.
In everyday life
Look for RTI-5152-12 outside the textbook — in sport, cooking, traffic, electronics or the sky above you. An example you found yourself is remembered far longer than one you were given.
Ask Teacher Smith questions about this articleOpens your AI tutor with a question about “RTI-5152-12” →

Affiliate

Preply — study more efficiently by working with a personal tutor. 50% off.

How to study RTI-5152-12 in 20 minutes

  1. Read the reference excerpt below once, without taking notes.
  2. Close the page and write down what RTI-5152-12 means in your own words.
  3. Compare your version with the excerpt and mark what you missed.
  4. Work through the three examples above with pen and paper.
  5. Explain RTI-5152-12 out loud to somebody else — or to Teacher Smith in the lgStudy chat.

Frequently asked questions

What is RTI-5152-12 in simple terms?

RTI-5152-12, or WW-12 (in patent), is a synthetic small-molecule agonist of the atypical chemokine receptor ACKR3 (CXCR7) that was derived from the naturally occurring alkaloid conolidine. RTI-5152-12 has 15-fold improved potency towards ACKR3 relative to conolidine.

Why does RTI-5152-12 matter?

Because it connects several science ideas at once: it gives you a definition you can apply, a quantity you can calculate, and a way to check whether a result is plausible.

How should I study RTI-5152-12?

Read the excerpt, restate it from memory, then work through the examples and applications listed on this page. The five-step study plan above takes about twenty minutes.

What does this page cover?

It gives you a compact reference excerpt plus original lgStudy explanations, examples, applications and study material on RTI-5152-12.

Tags

  • Indoles
  • Ketones
  • Opioid modulators
  • Opioid peptides
  • Piperidines

Keep exploring